Saturday, June 15, 2024

A Cutting-Edge Surgical Tool for Enhanced Precision and Safety: FDA Approves InnoVoyce’s VYLO Laser System

Similar articles

Medical use clearance has been granted by the U.S. Food and Drug Administration (FDA) for InnoVoyce’s VYLO Laser System, a sophisticated surgical tool engineered to deliver a broad range of surgical capabilities with enhanced safety and precision. This approval marks a significant advancement in medical technology, designed to address various surgical needs across multiple specialties.

The VYLO Laser System is a 455nm blue light laser capable of delivering up to 30W across four emission modes. It is specifically developed for a range of surgical procedures, including incision, excision, vaporization, and ablation. The system is also intended for hemostasis and coagulation of soft tissue, muscle, organs, and glands. This versatility allows the surgical tool to perform precise cuts as well as significant soft tissue mass removal, making it a valuable tool in various surgical settings.

The precision and efficacy of the surgical tool make it suitable for use in several medical fields, including gynecology, gastroenterology, and otorhinolaryngology. Its blue light lasers, which can emit beams between 400nm and 500nm, have demonstrated effectiveness in treating soft tissue conditions, particularly in voice health (laryngology) and ear, nose, and throat (ENT) medicine. The system’s ability to handle a variety of surgical tasks highlights its broad applicability and potential to improve patient outcomes across different medical specialties.

Advanced Surgical Tool with FiberSafe Technology for Enhanced Safety and Precision

One of the key features of the VYLO Laser System is its patent-pending FiberSafe technology. This safety feature automatically shifts the laser into standby mode if there is any flare-up along the fiber. This critical safety mechanism reduces operational risks and enhances the dependability of the surgical tool, ensuring that procedures are conducted with the highest level of safety and reliability.

Michael Davin, CEO of InnoVoyce, expressed the company’s commitment to innovation and advancing healthcare through scalable laser technologies. “InnoVoyce was established with a mission to introduce innovative solutions to treat the millions of individuals affected by voice disorders. The FDA’s clearance of the VYLO Laser System marks a significant milestone in our commitment to advancing healthcare with scalable laser technologies. This system is not only pivotal for vocal health but is also designed to effectively treat a variety of mucosal tissue conditions, highlighting its broad applications in medical treatment.”

The VYLO Laser System’s ability to deliver precise and efficient surgical interventions is supported by several advanced features. The surgical tool offers up to 30W power, ensuring effective tissue treatment across multiple surgical modes. Suitable for a range of applications including gynecology, gastroenterology, and ENT, as well as other surgical specialisms. The FiberSafe technology enhances operational safety by preventing potential risks associated with fiber flare-ups. Designed to streamline surgical procedures, the system reduces the time and complexity involved in various treatments.

Surgical Tool

InnoVoyce’s Cutting-Edge Surgical Tool Revolutionizes Medical Laser Technology

The clearance of the VYLO Laser System by the FDA positions InnoVoyce at the forefront of medical laser technology. With the ability to treat a wide array of conditions and its application across multiple medical fields, the surgical tool is expected to see significant adoption in hospitals and clinics. The focus on voice health, combined with its broader surgical capabilities, makes it a versatile and essential tool for modern medical practices.

The FDA’s clearance of the VYLO Laser System signifies a major advancement in the field of surgical laser technology. With its broad range of applications, enhanced safety features, and high precision, the surgical tool is poised to transform surgical procedures and improve patient care. InnoVoyce’s commitment to innovation and excellence is evident in the development of this cutting-edge device, which will undoubtedly make a significant impact on the medical community.

You can follow our news on our Telegram and LinkedIn accounts.

As the VYLO Laser System begins to be implemented in various medical settings, its ability to provide precise and reliable treatment will be crucial in addressing complex surgical needs and improving patient outcomes. This milestone underscores the importance of continued innovation in medical technology and the role of advanced devices in enhancing healthcare delivery.


Resource: InnoVoyce, May 30, 2024

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article